Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: A comparative study
Introduction
Vasculitic neuropathy occurs in association with various diseases including systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, infection, malignant neoplasia, and cryogloblinemia [1]. In addition to vasculitic neuropathies secondarily to these diseases, primary systemic vasculitides including microscopic polyangiitis (MPA), Churg-Strauss syndrome, and Wegener's granulomatosis are known to involve the peripheral nervous system. Finally, vasculitis confined to the peripheral nervous system without systemic manifestations has been reported [2], [3]. Subsequently, Dyck et al. described 20 patients with vasculitic neuropathy in the absence of other organ involvement [4]. These patients showed few laboratory abnormalities suggesting either systemic inflammation or collagen diseases, lacked nonspecific constitutional symptoms such as fever or weight loss, and had a favorable prognosis [4]. Since then, such vasculitic neuropathy has been known as nonsystemic vasculitic neuropathy (NSVN) and has attracted attention mainly among neurologists. Although NSVN possesses distinctive clinical features, involving only the peripheral nervous system, pathogenesis has remained unknown. In addition, vasculitis in this neuropathy has not been proven pathologically to be confined to the peripheral nervous system, so it might subclinically involve other organs. A related question is whether NSVN has a pathogenesis distinct from that of systemic vasculitides, especially MPA. MPA, a vasculitis involving small vessels including arterioles, venules, or capillaries [5], originally was considered a subtype of polyarteritis nodosa with rapidly progressive necrotizing glomerulonephritis and sometimes lung hemorrhage [6]; because of frequent renal involvement [5], this disorder has been studied by nephrologists as well as rheumatologists, with far less attention given to its neurologic aspects [5], [7]. Since diagnostic criteria for primary vasculitis, such as those of Chapel Hill Consensus Conference [7], have been established mainly by rheumatologists, the nosologic relationship of systemic vasculitides to NSVN has remained obscure.
In this study we compared clinicopathologic features of neuropathy without and with systemic involvement (so-called NSVN and MPA-associated neuropathy: MPAN) to clarify the relationship of NSVN to systemic vasculitic neuropathy.
Section snippets
Patients
Clinicopathologic findings in consecutive patients with pathologically confirmed NSVN and MPA-associated neuropathy (MPAN) with systemic involvement who were referred to Nagoya University Graduate School of Medicine and performed sural nerve biopsy from 1990 to 2003 were retrospectively compared. In the NSVN group symptoms of vasculitis were confined solely to the peripheral nerves, with no clinical or laboratory evidence of other organ involvement [4]. Laboratory data in this group were normal
General symptoms
Age at onset was significantly younger in the NSVN group than the MPAN group (58.4 ± 15.3 versus 67.2 ± 8.0 years; p < 0.05; Table 1). The male to female ratio was 1.6:1 in NSVN and 1.9:1 in MPAN. Nonspecific symptoms, specifically fever, weight loss, skin eruption, arthralgia, and myalgia, respectively were seen in 83%, 43%, 30%, 13% and 13% of MPAN patients; these symptoms were absent in NSVN patients. In the MPAN group, renal involvement was present in 38% of patients, and pulmonary involvement in
Discussion
Although NSVN is clinically distinctive from other systemic vasculitides such as MPA in that clinically apparent vasculitis is confined to the peripheral nervous system, uncertainty prevails as to whether NSVN is likely to have a distinct etiology and pathogenesis and to represent an independent disease entity. The nosologic relationship between NSVN and MPA-associated neuropathy (MPAN) therefore remains in question. Although MPA frequently involves lung and kidney, the Chapel Hill consensus
References (35)
- et al.
Necrotizing small-vessel vasculitis confined to the uterine cervix
Semin Arthritis Rheum
(2000) - et al.
Isolated renal giant cell arteritis
Am J Kidney Dis
(2002) Neuromuscular complications of connective tissue diseases
Muscle Nerve
(2001)- et al.
Periarteritis nodosa: clinicopathologic study with special reference to the nervous system
Arch Neurol Psychol
(1938) - et al.
The clinical spectrum of necrotizing angiopathy of the peripheral nervous system
Ann Neurol
(1985) - et al.
Nonsystemic vasculitic neuropathy
Brain
(1987) - et al.
Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients
Arthritis Rheum
(1999) - et al.
The kidney in periarteritis nodosa
Q J Med
(1948) - et al.
Nomenclature of systemic vasculitides. Proposal of an international consensus conference
Arthritis Rheum
(1994) - et al.
Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group
Br J Rheumatol
(1996)
Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy
Neurology
Interobserver agreement for the assessment of handicap in stroke patients
Stroke
Principles of nerve conduction studies
Assessment of individual nerves
Expression of nerve growth factor receptor in human peripheral neuropathies
Ann Neurol
X-linked recessive bulbospinal neuronopathy. A clinicopathological study
Brain
Clinicopathological features of Churg-Strauss syndrome-associated neuropathy
Brain
Cited by (67)
Peripheral neuropathies during systemic diseases: Part II (vasculitis)
2023, Revue de Medecine InternePeripheral Nerve Vasculitis: Classification and Disease Associations
2019, Neurologic ClinicsVasculitic peripheral neuropathy: Case definition and guidelines for collection, analysis, and presentation of immunisation safety data
2017, VaccineCitation Excerpt :Traditionally, most pathologists have required not only vascular inflammation but also changes indicative of vascular damage or compromise, a more specific approach [25–27]. For peripheral nerve vasculitis, in particular, many groups have published non-uniform diagnostic criteria for histopathologically definite and probable vasculitic neuropathy based on cutaneous nerve biopsy findings in patients presenting with a peripheral neuropathy [7,9,28–36]. In 2007–2010, a task force of vasculitic neuropathy experts assembled by the PNS reviewed the literature on vasculitis and vasculitic neuropathy and then derived the first and only consensus definitions of histopathologically definite, probable, and possible vasculitic neuropathy, which were modified from the previous non-consensus definitions [6].
Peripheral Neuropathies
2015, Nerves and Nerve Injuries: Pain, Treatment, Injury, Disease and Future Directions: Vol 2Vasculitic Neuropathy
2014, Encyclopedia of the Neurological SciencesGranuloma, vasculitis, and demyelination in sarcoid neuropathy
2024, European Journal of Neurology